Dallas, TX · FDA Reclassification Pending Q3 2026

Peptide clinics in Dallas, TX.
The directory for when your state opens.

A vetted list of licensed physicians and 503A compounding pharmacies preparing to serve Dallas the moment the FDA finalizes Category 2 reclassification. We do not sell peptides. We connect you with practitioners who do this work the right way.

Why peptides · why now

The window Dallas has been waiting on is almost open.

Dallas-Fort Worth is one of the largest concierge medicine markets in the country. The corridor that runs from Park Cities through Preston Hollow up toward Plano and Frisco has been quietly building age-management and hormone-optimization protocols for two decades. Executive practices around Uptown, Knox-Henderson, and the Stemmons corridor see a steady stream of high-performing patients in their forties and fifties who are already running labs annually and treating the GH/IGF-1 axis as a domain worth understanding. What is changing now is the federal regulatory frame around growth-hormone-axis peptides, and the Dallas clinics that have been waiting on a clean legal lane are about to get one.

The short version: in 2023 the FDA placed several named peptides — including BPC-157, KPV, TB-500, MOTs-C, and others — into Category 2 of the 503A bulk substances list, which restricts but does not prohibit compounding. On April 16, 2026 a Federal Register notice reopened the nominations process. The Pharmacy Compounding Advisory Committee (PCAC) is scheduled to meet July 23–24, 2026 to review the science and vote on whether those compounds move into Category 1 (clearly compoundable under 503A) or stay in Category 2. Whatever the committee decides, the Dallas providwrs preparing for that meeting are about to be in a very different position than they were a year ago.

Texas itself has been steady. The Texas State Board of Pharmacy permits 503A compounding for individual patient prescriptions, and the Texas Medical Board has consistently treated bioidentical hormone work and peptide therapy as practice-of-medicine questions for the physician-patient relationship. That is one reason the Dallas longevity and endocrinology practices have continued to work with licensed compounding pharmacies throughout the Category 2 period. Find Peptide Clinics exists to make that legitimate, licensed lane easy to find — and to make the gray-market storefronts easy to avoid.

Top peptides · Anti-aging and longevity

The compounds Dallas clinics are preparing to offer.

Dallas peptide search demand skews toward anti-aging and longevity, which in clinical practice means the growth-hormone axis, tissue repair, and skin and collagen support. These are the named compounds practitioners in this market are most likely to discuss with you — each restricted under FDA Category 2 today, each pending reclassification review.

Sermorelin
GHRH analog · pulsatile GH

A growth-hormone-releasing hormone analog that prompts the pituitary to release endogenous growth hormone in its natural pulse pattern, rather than supplying exogenous GH directly. Long history of clinical use, generally well-tolerated in adults under physician supervision.

Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006. PMC2699646

Tesamorelin
GHRH analog · visceral fat · liver

FDA-approved as Egrifta for HIV-associated lipodystrophy; studied in non-HIV populations for visceral adiposity and non-alcoholic fatty liver disease. Discussed widely in Dallas executive-health practices for central adiposity in patients over forty-five.

Stanley TL, et al. Effects of tesamorelin on visceral fat and liver fat. JAMA. PMC8366828

GHK-Cu
Copper tripeptide · skin · regenerative

A naturally occurring copper-binding tripeptide present in human plasma at levels that decline with age. Demonstrated activity on wound healing, dermal collagen, and gene expression patterns associated with younger tissue. Commonly compounded as a topical in Dallas aesthetic-adjacent longevity practices.

Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci. 2018. PMC6073405 · Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015. PMC4508379

BPC-157
Pentadecapeptide · cytoprotectant

A stable gastric peptide studied for cytoprotective and tissue-repair signaling. Dallas's orthopedic-adjacent longevity and sports-medicine practices follow this compound closely. Currently in FDA Category 2 and one of the four compounds the July 2026 PCAC meeting will review for reclassification.

Whitehouse MW, et al. BPC-157 as a cytoprotectant: review of preclinical evidence. 2025. PMC12396989

Growth hormone axis (clinical context)
Endocrine · aging review

For patients curious about why so much of peptide work points back to growth-hormone-releasing signals, this 2025 clinical review is the cleanest summary of the current evidence base on the GH/IGF-1 axis in aging. Worth reading before your first consult. For a parallel doctor-authority market with the same protocol patterns, see our Oklahoma City directory.

Bartke A. Growth hormone and aging: a clinical review. 2025. PMC12009952

How to find a clinic in Dallas

The questions that actually separate a real clinic from a storefront.

Three or four questions, asked in this order, will tell you within ten minutes whether a Dallas provider is operating under federal compounding law or is something you should walk away from. Dallas is large enough that you will see both kinds. The screem is straightforward.

Which 503A pharmacy fills your prescriptions?
A legitimate Dallas clinic will name the pharmacy without hesitation — usually a Texas-licensed or out-of-state 503A facility with a documented prescriber relationship. Verify the license through the Texas State Board of Pharmacy in about two minutes. If the answer is "we keep our supply in-house," that is a 503B, a research-chemical reseller, or worse. Walk away.
Will you run baseline bloodwork before prescribing?
For anything in the growth-hormone axis the answer must be yes. At minimum a comprehensive metabolic panel, IGF-1, a hormone panel relevant to your sex and age, and inflammatory markers. A clinic that writes a sermorelin or tesamorelin script without baseline labs is not practicing medicine; it is running a subscription. For a comparison of how other doctor-authority markets handle baseline workup, see our Nashville, TN directory.
What does the follow-up cadence look like?
Six-to-twelve week re-labs are the standard of care for GH-axis peptides. Clinics that hand you a six-month supply with no scheduled follow-up are not the ones you want. The good Dallas practices structure this as a clinical relationship, not a transaction.
How do you handle the July 2026 PCAC review?
A clinic worth your time is tracking the Federal Register and PCAC agenda directly and can explain to you, in plain language, what changes if BPC-157, KPV, TB-500, or MOTs-C move out of Category 2 and what stays the same. If they cannot answer that question, they are not paying attention to the law that governs their own practice.
Verified Dallas clinics

Practitioners we've confirmed.

We are still verifying clinics in Dallas. Every listing on this site is confirmed against state licensure records and 503A compounding pharmacy relationships before it appears — we will not publish a clinic we cannot stand behind. Join the waitlist below and you'll be the first told when verified Dallas providers are added.
Priority Access · Dallas, TX

Get notified the moment Dallas clinics open.

Join the Dallas list

Be first in line for verified Dallas peptide clinics.

We send one email when Texas is cleared. No spam. Unsubscribe anytime.

We do not prescribe, dispense, or ship peptides.

Straight Answers · Dallas

What you should know before joining the Dallas list.

Are peptides legal in Dallas right now?
Peptide therapy is legal in Dallas when prescribed by a Texas-licensed physician and prepared by a 503A compounding pharmacy operating under federal compounding law. Texas Pharmacy Board rules permit 503A compounding for individual patient prescriptions. The FDA placed several named peptides into Category 2 in 2023, restricting but not prohibiting compounding. A Federal Register notice published April 16, 2026 reopened the nominations process, and the Pharmacy Compounding Advisory Committee will meet July 23–24, 2026 to review BPC-157, KPV, TB-500, and MOTs-C. Until that meeting concludes, Category 2 status holds.
Will Find Peptide Clinics sell me peptides?
No. We do not sell peptides. We maintain a directory of licensed physicians and 503A compounding pharmacies in Dallas who may prescribe and prepare them under federal law.
What does a peptide clinic in Dallas actually do?
A legitimate Dallas peptide clinic conducts a full intake, runs baseline labs (CMP, IGF-1, hormone panel, inflammatory markers), discusses goals and contraindications, and only then writes a prescription that a partnered 503A pharmacy compounds patient-specific. Follow-up labs are scheduled at six to twelve weeks. The clinic does not stock vials. See our Charlotte, NC directory for a parallel example.
How do I know a Dallas clinic is legitimate?
Three checks. First, ask which 503A pharmacy fills their prescriptions and verify that pharmacy's license through the Texas State Board of Pharmacy. Second, confirm the prescriber's Texas medical license through the Texas Medical Board lookup. Third, ask whether they require baseline bloodwork before prescribing anything in the growth-hormone axis. If any answer is evasive, walk away.
Are the peptides themselves FDA-approved?
Most peptides discussed in anti-aging contexts are not FDA-approved as finished drug products for the indications patients ask about. They are compounded pursuant to a valid prescription by a 503A pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act. Tesamorelin (Egrifta) is FDA-approved for HIV-associated lipodystrophy and is sometimes prescribed off-label. Semaglutide is FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy).
How much does peptide therapy cost in Dallas?
Dallas cost ranges $300–$1,400 per month depending on peptide, pharmacy, and whether bloodwork is bundled. Park Cities and Preston Hollow concierge practices sit at the high end. Initial consult plus baseline labs runs $300–$800 separately. Insurance does not reimburse compounded peptides. For a deeper breakdown see our main FAQ.